A phase I followed by a randomized phase II trial of two...

Trials 2016 / 12 Vol. 17; Iss. 1

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

Schouten, Philip C., Dackus, Gwen M. H. E., Marchetti, Serena, van Tinteren, Harm, Sonke, Gabe S., Schellens, Jan H. M., Linn, Sabine C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Trials
DOI:
10.1186/s13063-016-1423-0
Date:
December, 2016
File:
PDF, 663 KB
english, 2016
Conversion to is in progress
Conversion to is failed